Showing results (11-20 of 2,440) with videos related to
Sort By:
Pageof 244
Diabetology & Metabolic Syndrome|December 22, 2022
Use of glucagon in severe hypoglycemia is scarce in most countries, and has not been expanded by new ready-to-use glucagonsAntonio E Pontiroli, Manfredi Rizzo, Elena TagliabueDiabetology & Metabolic Syndrome|January 1, 2023
Interactive effects of intrinsic capacity and obesity on the KDIGO chronic kidney disease risk classification in older patients with type 2 diabetes mellitusWei-Hua Tang, Teng-Hung Yu, Hui-Lan Lee, et al.Diabetology & Metabolic Syndrome|January 2, 2023
2022: Position of Brazilian Diabetes Society on exercise recommendations for people with type 1 and type 2 diabetesWilliam Valadares Campos Pereira, Denise Maria Martins Vancea, Ricardo de Andrade Oliveira, et al.Diabetology & Metabolic Syndrome|December 26, 2022
Association of glucagon-like peptide-1 receptor agonists with cardiac arrhythmias in patients with type 2 diabetes or obesity: a systematic review and meta-analysis of randomized controlled trialsSijin Wu, Wenzhao Lu, Zhongli Chen, et al.Diabetology & Metabolic Syndrome|June 21, 2022
A pilot study on the effect of D-allulose on postprandial glucose levels in patients with type 2 diabetes mellitus during Ramadan fastingSalimah Japar, Kensaku Fukunaga, Toshihiro Kobayashi, et al.Diabetology & Metabolic Syndrome|December 2, 2022
Effects of vildagliptin on wound healing and markers of inflammation in patients with type 2 diabetic foot ulcer: a prospective, randomized, double-blind, placebo-controlled, single-center studyVenkat N Vangaveti, Shaurya Jhamb, Oliver Hayes, et al.Diabetology & Metabolic Syndrome|November 29, 2022
Healthcare costs associated with comorbid cardiovascular and renal conditions among persons with diabetes, 2008-2019Chintal H Shah, Chintan V DaveDiabetology & Metabolic Syndrome|November 29, 2022
Hypoglycemia unawareness identified by continuous glucose monitoring system is frequent in outpatients with type 2 diabetes without receiving intensive therapeutic interventionsBingkun Huang, Qiuhui Jiang, Ting Wu, et al.Diabetology & Metabolic Syndrome|May 3, 2022
Clinical and humanistic impact of pharmacotherapeutic follow-up in patients with type 1 diabetes mellitus treated judiciallyThays S Mendonça, William N Oliveira, Vinícius S Belo, et al.Diabetology & Metabolic Syndrome|May 3, 2022
NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetesMarcus Vinicius Bolivar Malachias, Magnus Olof Wijkman, Marcello Casaccia BertoluciPageof 244